Skip to main content
Erschienen in: Virchows Archiv 3/2016

14.06.2016 | Case Report

Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)

verfasst von: Antonio García Escudero, Enrique Rodríguez Zarco, Juan Carlos Girón Arjona, María José Ríos Moreno, Katherine Gallardo Rodríguez, Ana Vallejo Benítez, Ricardo González Cámpora

Erschienen in: Virchows Archiv | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

DIPNECH is characterized by neuroendocrine cell hyperplasia, tumorlets, and eventually carcinoid tumors. Although it is regarded by some authors as a preneoplastic condition, this issue is controversial. New pathologic criteria have recently been proposed for the diagnosis of DIPNECH, and a subgroup of carcinoid tumors expressing developing neural transcription factors (DNTFs), with clinicopathologic features similar to those of DIPNECH, has been recognized. This paper reports on the clinical and pathological findings in three cases of DIPNECH and investigates the expression of three DNTFs (TTF1, ASCL1, and POU3F2). All patients were female, with a mean age of 63 years, and all lesions were located in the periphery of the lung. In two cases, typical carcinoids were associated with a spindle-cell component. All neuroendocrine proliferations were DNTF positive. The morphologic (spindle-cell component), phenotypic (DNTF expression), and clinicopathologic (peripheral tumors, female predominance) similarities suggest that DIPNECH may be a preneoplastic lesion for peripheral carcinoids.
Literatur
1.
Zurück zum Zitat Davies SJ, Gosney JR, Hansell DM et al (2007) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62:248–252CrossRefPubMed Davies SJ, Gosney JR, Hansell DM et al (2007) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 62:248–252CrossRefPubMed
2.
Zurück zum Zitat Gosney JR, Austin JHM, Jett J et al (2015) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds) Tumors of the lung, pleura thymus and heart. IARC Press, Lyons, pp 78–79 Gosney JR, Austin JHM, Jett J et al (2015) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (eds) Tumors of the lung, pleura thymus and heart. IARC Press, Lyons, pp 78–79
3.
Zurück zum Zitat Aguayo SM, Miller YE, Waldron JA Jr et al (1992) Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. New Engl J Med 327:1285–1288CrossRefPubMed Aguayo SM, Miller YE, Waldron JA Jr et al (1992) Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. New Engl J Med 327:1285–1288CrossRefPubMed
4.
Zurück zum Zitat Wirtschafter E, Walts AE, Liu ST, Marchevsky AM (2015) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia of the lung (DIPNECH): current best evidence. Lung 193:659–667CrossRefPubMed Wirtschafter E, Walts AE, Liu ST, Marchevsky AM (2015) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia of the lung (DIPNECH): current best evidence. Lung 193:659–667CrossRefPubMed
5.
Zurück zum Zitat Travis WD, Colby TV, Corrin B, Shimosato Y, Branbilla E (1999) Histological typing of lung and pleural tumors. In: World Health Organization International Histological Classification of Tumours, vol 3rd. Springer, Berlin Travis WD, Colby TV, Corrin B, Shimosato Y, Branbilla E (1999) Histological typing of lung and pleural tumors. In: World Health Organization International Histological Classification of Tumours, vol 3rd. Springer, Berlin
6.
Zurück zum Zitat Gorshtein A, Gross DJ, Barak D et al (2012) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. Cancer 118:612–619CrossRefPubMed Gorshtein A, Gross DJ, Barak D et al (2012) Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. Cancer 118:612–619CrossRefPubMed
7.
Zurück zum Zitat Yazawa T (2015) Recent advances in histogenesis research of lung neuroendocrine cancers: evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors. Pathol Int 65:277–285CrossRefPubMed Yazawa T (2015) Recent advances in histogenesis research of lung neuroendocrine cancers: evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors. Pathol Int 65:277–285CrossRefPubMed
8.
Zurück zum Zitat Nishikawa E, Osada H, Okazaki Y et al (2011) miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 71:6165–6173CrossRefPubMed Nishikawa E, Osada H, Okazaki Y et al (2011) miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res 71:6165–6173CrossRefPubMed
9.
Zurück zum Zitat Kashiwagi K, Ishii J, Sakaeda M et al (2012) Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells. Pathol Int 63:232–245CrossRef Kashiwagi K, Ishii J, Sakaeda M et al (2012) Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells. Pathol Int 63:232–245CrossRef
10.
Zurück zum Zitat Yazawa T, Kamma H, Fujiwara M et al (1999) Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J Pathol 187:191–199CrossRefPubMed Yazawa T, Kamma H, Fujiwara M et al (1999) Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J Pathol 187:191–199CrossRefPubMed
11.
Zurück zum Zitat Osada H, Tomida S, Yatabe Y et al (2008) Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 68:1647–1655CrossRefPubMed Osada H, Tomida S, Yatabe Y et al (2008) Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 68:1647–1655CrossRefPubMed
12.
Zurück zum Zitat Lazzaro D, Price M, De Felice M, Di Lauro R (1991) The transcription factor is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the fetal brain. Development 113:1093–1104PubMed Lazzaro D, Price M, De Felice M, Di Lauro R (1991) The transcription factor is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the fetal brain. Development 113:1093–1104PubMed
13.
Zurück zum Zitat Hosono Y, Yamaguchi T, Mizutani E et al (2012) MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J 31:481–493CrossRef Hosono Y, Yamaguchi T, Mizutani E et al (2012) MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis. EMBO J 31:481–493CrossRef
14.
Zurück zum Zitat Saito RA, Watabe T, Horiguchi K et al (2009) Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res 69:2783–2791CrossRefPubMed Saito RA, Watabe T, Horiguchi K et al (2009) Thyroid transcription factor-1 inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Cancer Res 69:2783–2791CrossRefPubMed
15.
Zurück zum Zitat Ishii J, Sato H, Yazawa T et al (2014) Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation. Pathol Int 64:415–422CrossRefPubMed Ishii J, Sato H, Yazawa T et al (2014) Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation. Pathol Int 64:415–422CrossRefPubMed
16.
Zurück zum Zitat Endo T, Yazawa T, Shishido-Hara Y et al (2014) Expression of developing neural transcription factors in lung carcinoid tumors. Pathol Int 64:365–374CrossRefPubMed Endo T, Yazawa T, Shishido-Hara Y et al (2014) Expression of developing neural transcription factors in lung carcinoid tumors. Pathol Int 64:365–374CrossRefPubMed
17.
Zurück zum Zitat Folpe AL, Gown AM, Lamps LW et al (1999) Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12:5–8PubMed Folpe AL, Gown AM, Lamps LW et al (1999) Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 12:5–8PubMed
18.
Zurück zum Zitat Andersen B, Rosenfeld MG (2001) POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human diseases. Endocr Rev 22:2–35PubMed Andersen B, Rosenfeld MG (2001) POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human diseases. Endocr Rev 22:2–35PubMed
19.
Zurück zum Zitat Augustyn A, Borromeo M, Wang T et al (2014) ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci U S A 111:14788–14793CrossRefPubMedPubMedCentral Augustyn A, Borromeo M, Wang T et al (2014) ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers. Proc Natl Acad Sci U S A 111:14788–14793CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Sturm N, Rossi G, Lantuejoul S et al (2002) Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 33:175–182CrossRef Sturm N, Rossi G, Lantuejoul S et al (2002) Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 33:175–182CrossRef
21.
Zurück zum Zitat Du EZ, Goldstraw P, Zacharias J et al (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35:825–831CrossRefPubMed Du EZ, Goldstraw P, Zacharias J et al (2004) TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location. Hum Pathol 35:825–831CrossRefPubMed
22.
Zurück zum Zitat Gosney JR, Williams IJ, Dodson AR, Foster CS (2011) Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 59:751–762CrossRefPubMed Gosney JR, Williams IJ, Dodson AR, Foster CS (2011) Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH). Histopathology 59:751–762CrossRefPubMed
23.
Zurück zum Zitat Marchevsky AM, Wirtschafter E, Walts AE (2015) The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Hum Pathol 46:176–181CrossRef Marchevsky AM, Wirtschafter E, Walts AE (2015) The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH? Hum Pathol 46:176–181CrossRef
Metadaten
Titel
Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)
verfasst von
Antonio García Escudero
Enrique Rodríguez Zarco
Juan Carlos Girón Arjona
María José Ríos Moreno
Katherine Gallardo Rodríguez
Ana Vallejo Benítez
Ricardo González Cámpora
Publikationsdatum
14.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 3/2016
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-016-1962-5

Weitere Artikel der Ausgabe 3/2016

Virchows Archiv 3/2016 Zur Ausgabe

Review and Perspectives

The spectrum of ectopic thymomas

Neu im Fachgebiet Pathologie